IBC is a clinical diagnosis and the peculiar differences with other forms of breast cancer are related to the TME and the host. rdcu.be/dFkNL IBC Foundation Wendy Woodward MDPhD Cristofanilli CTC Laboratory

Join Professor Johann De Bono at the 20th Anniversary of Circulating Tumor Cells in Granada, Spain from May 24-25, 2024.

Professor Johann de Bono is Regius Professor of Cancer Research at The Institute of Cancer Research and honorary consultant in medical oncology at The Royal…

Development of endocrine resistance can be associated with loss of ER expression in CTCs. Expanding liquid biopsy assessment in HR+ MBC. Cristofanilli CTC Laboratory WCM Englander Institute for Precision Medicine International Society of Liquid Biopsy Weill Cornell Medicine Meyer Cancer Center

The beginning of liquid biopsy in breast cancer. How an intuition became a revolution. International Society of Liquid Biopsy M JOSE SERRANO (LB&Cancer Interception group) Christian Rolfo David Gandara WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center #MBC #AACR24

Understanding breast cancer complexity by blood-based genomics and cancer cells testing WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center International Society of Liquid Biopsy

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases | New England Journal of Medicine nejm.org/doi/full/10.10… Continued de-escalation of local therapies in breast cancer.

PACE: Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Oncology ascopubs.org/doi/10.1200/JC…

In details, only 20.2% completed planned treatment and not obvious reasons for 3 years; half completed 2 years; discontinuation of treatment in <20%;< 2% Black women. Further follow-up needed. WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center

That’s a wrap! It’s been an inspiring time at Focus on TOP #FTOP24 !

Thanks to our amazing faculty and to everyone who joined us, see you next year!

Fabio Puglisi Massimo Cristofanilli, MD, FACP Umberto Malapelle Maria Vittoria Dieci Luca Malorni Gustavo Baldassarre Rossana Roncato Marzia Del Re, PharmD, PhD

#Oncology #liquidbiopsy

Join Francois-Clement Bidard at the 20th Anniversary of Circulating Tumor Cells in Granada, Spain from May 24-25, 2024.

Francois-Clement Bidard, MD PhD, is a Professor of Medical Oncology at Institut Curie & Versailles University, and also the vice-chair or the French breast…

Perfect timing for the study to be published NEJM.

#ctDNA 🩸blood test for screening for colorectal cancer
✔️83% sensitivity
✔️90% specificity

March is #ColorectalCancerAwarenessMonth

🩸is more practical 🆚 colonoscopy or 💩 test. Unmet need. OncoAlert
nejm.org/doi/full/10.10…

Dr. Uhr was a visionary pioneer for his initial work on CTCs in solid tumors leading to the clinical testing of the first enrichment method for enumeration and molecular analysis Cristofanilli CTC Laboratory M JOSE SERRANO (LB&Cancer Interception group) Umberto Malapelle David Gandara Christian Rolfo WCM Englander Institute for Precision Medicine

ISLB 2024 IS COMING, SAVE THE DATE.

🚨🔔ISLB 2024 - Save The Date! 23-25 November 2024 in Denver Colorado!. 🏔️🌆Subscribe for the newsletter and prepare your abstracts!! ⁦M JOSE SERRANO (LB&Cancer Interception group)⁩ ⁦Umberto Malapelle⁩ ⁦David Gandara⁩ ⁦Massimo Cristofanilli, MD, FACP⁩ ⁦ELO⁩ ⁦ 2024.islb.info

Please join us to celebrate 20 years of liquid biopsy history: research, clinical applications and change in practice. WCM Englander Institute for Precision Medicine Massimo Cristofanilli, MD, FACP Weill Cornell Medicine Meyer Cancer Center Cristofanilli CTC Laboratory Christian Rolfo M JOSE SERRANO (LB&Cancer Interception group)

We can reduce worldwide cancer mortality by promoting equity in access to early detection and better care.
worldcancerday.org/sites/default/…
#WorldCancerDay WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center International Society of Liquid Biopsy Lisa Newman, MD MPH Dawn Hershman

Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial academic.oup.com/oncolo/article… Cristofanilli CTC Laboratory WCM Englander Institute for Precision Medicine WCM Englander Institute for Precision Medicine #MBC

Prospective Evaluation of Circulating Tumor DNA using NGS During Neoadjuvant Chemotherapy in Pancreatic Cancer: Annals of Surgery journals.lww.com/annalsofsurger… WCM Englander Institute for Precision Medicine Cristofanilli CTC Laboratory International Society of Liquid Biopsy

Monitoring MRD and patients attitude should be considered a new measure of quality of care for emotional wellbeing and clinical outcomes. International Society of Liquid Biopsy WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center

Happy Holidays from the International Society of Liquid Biopsy! 🌟

May your days be filled with warmth, laughter, and the joy of shared moments. 🥂 As we wrap up the year, we want to express our gratitude for your continued support and trust. Thank you for being a part of our…